DPAn-6 by gavage reduced neuroinflammation, microgliosis, and apoptosis, and it improved neuroprotective gene expression in the late stage of our AD models with advanced AD pathology against the background of APOE4, a strong genetic risk factor for late-onset AD (Figure 8). The gene discussed is APOE; the disease is Alzheimer disease.